Lower-dose heparin use during coronary procedure does not appear to reduce risk of major bleeding

Tuesday, August 31, 2010 - 06:14 in Health & Medicine

Patients with acute coronary syndromes initially treated with the anticoagulant fondaparinux who underwent a coronary procedure (such as balloon angioplasty) and received a lower dose of the...

Read the whole article on Science Blog

More from Science Blog

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net